Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kuse

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative GroupT Büchner, D Urbanitz, W Hiddemann, et al.
Annals of Hematology|October 31, 1998
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative GroupW Kern, C Aul, G Maschmeyer, et al.
Clinical Transplantation|June 27, 1998
Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?O K Eberhard, I Langefeld, E R Kuse, et al.
Der Anaesthesist|April 1, 1996
[Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation]E R Kuse, M Meyer, R Constantin, et al.
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 16, 2006
ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantationA Weimann, M Braga, L Harsanyi, et al.
Acta Haematologica|February 29, 2000
Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failureN Kröger, C Rauhöft, W Zeller, et al.
Journal of Hepatology|February 24, 2007
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrationJens Rosenau, Therese Kreutz, Matthias Kujawa, et al.
Leukemia|January 9, 2004
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromesM Stadler, U Germing, K-O Kliche, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative GroupT Büchner, D Urbanitz, W Hiddemann, et al.
Annals of Hematology|October 31, 1998
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative GroupW Kern, C Aul, G Maschmeyer, et al.
Clinical Transplantation|June 27, 1998
Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?O K Eberhard, I Langefeld, E R Kuse, et al.
Der Anaesthesist|April 1, 1996
[Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation]E R Kuse, M Meyer, R Constantin, et al.
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 16, 2006
ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantationA Weimann, M Braga, L Harsanyi, et al.
Acta Haematologica|February 29, 2000
Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failureN Kröger, C Rauhöft, W Zeller, et al.
Journal of Hepatology|February 24, 2007
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administrationJens Rosenau, Therese Kreutz, Matthias Kujawa, et al.
Leukemia|January 9, 2004
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromesM Stadler, U Germing, K-O Kliche, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Pageof 11